ILSI North America hosts Dr. Jaeyun Sung of the Mayo Clinic to discuss with participants the development of a gut microbiome-based health index.
With multiple studies showing that COVID deaths and complications increase step-by-step with increasing blood sugar levels, a groundbreaking Newswise Webinar on Thursday November 12th from 2 to 3 pm ET will examine national, clinical and community strategies to immediately improve COVID outcomes through comprehensive nutrition information and action.
ALEXANDRIA, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that COVID-19 coagulation impairment, driven in part by endothelial Factor VIII, is associated with liver injury in infected patients. The study’s findings also show that IL-6 trans-signaling, which may play a role in COVID-19 development, results in prothrombotic liver sinusoidal endothelial cells (LSECs) that may mediate the liver injury via elevated Factor VIII and activation of coagulation in the liver microvasculature.
A new study published online in the Annals of the American Thoracic Society reveals how patients hospitalized with severe COVID-19 fared, compared to those hospitalized with severe seasonal influenza. The study is believed to be the first in the U.S. to directly compare clinical features, laboratory results and health outcomes between patients with the two diseases.
A new study being presented at this year’s virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting examined hospital data and determined those with allergic conditions did not have more severe COVID-related disease than those without.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI analiza los datos de los hospitales para determinar si aquellas personas con condiciones alérgicas tenían enfermedades más graves relacionadas con el COVID en comparación con aquellas que no las tenían.
Researchers have discovered a previously unknown way that pancreatic cells decide how much insulin to secrete. It could provide a promising new target to develop drugs for boosting insulin production in people with Type 2 diabetes.
During the coronavirus pandemic, the Centers for Disease Control continue to recommend that everyone wear a mask in public, or any place where there are other people, to minimize the transmission of COVID-19. But is it safe to wear a mask for a prolonged period of time? Can a mask restrict oxygen intake or cause a buildup of carbon dioxide? “As a pulmonologist, I can assure you that for most people wearing a mask is safe,” said Daniel F. Dilling, MD, Loyola University Medical Center pulmonologist and critical care medicine specialist. “I wear a mask every day. Most masks do not limit the amount of air that you breathe in, nor decrease your body’s ability to fight COVID-19. “Most importantly, masks work,” said Dr. Dilling, who is featured in the new Loyola Medicine video, “Coronavirus (COVID-19): Do Face Masks Restrict air Flow?”
The findings, published today
A new study from the USC Leonard Davis School of Gerontology shows that the behavioral responses to COVID-19 differed by age.
People of Black ethnicity are twice as likely to be infected with COVID-19 compared to those of White ethnicity, according to researchers at the Universities of Leicester and Nottingham, supported by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre. The findings are published in EClinical Medicine by The Lancet today (Thursday 12 November 2020).
Neurologists are researching whether a novel immunomodulatory treatment, OP-101, can dampen lung and brain injury in hospitalized COVID-19 patients through a clinical trial at The University of Texas Health Science Center at Houston UTHealth).
Researchers at Washington University School of Medicine in St. Louis have completed a clinical trial suggesting that the antidepressant drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.
A new national survey by The Ohio State University Wexner Medical Center finds that although a majority of Americans plan to take precautions at holiday gatherings, such as social distancing and asking those with COVID symptoms not to attend, many will also put themselves at risk.
The COVID-19 Research Symposium, hosted by the Mount Sinai Clinical Intelligence Center (MSCIC), is a one-day comprehensive review of advances in research by the Mount Sinai Health System to better understand and treat the coronavirus known as COVID-19.
In a study published today in Scientific Reports, a Nature Research Journal, a team of researchers led by Dr. Joseph Fisher presents a proof of concept of a simple method that could become a game-changer in rescue therapy for severe alcohol intoxication, as well as just “sobering up.”
An international team led by UCLA Fielding School of Public Health researchers has developed and tested two strategies for sustaining economic activity during the COVID-19 pandemic
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right